Abstract
Background
Ginseng-containing traditional medicine preparations (G-TMPs) in combination with fluoropyrimidine-based chemotherapy (FBC) are well-known treatments for advanced gastric cancer (AGC), with a superior efficacy to FBC alone. However, evidence regarding their efficacy remains limited. The purpose of this meta-analysis is to evaluate the efficacy and safety of G-TMPs in combination with FBC for the treatment of AGC.
Methods
Eight electronic databases were searched for randomized controlled trials (RCTs) using G-TMPs with FBC for the treatment of AGC. The primary outcome included the tumor response, while the secondary outcomes included the quality of life (QoL), proportions of peripheral blood lymphocytes, adverse drug reactions (ADRs), and levels of cancer biomarkers. The quality of evidence for each outcome was assessed using GRADE profilers.
Results
A total of 1,960 participants were involved in the 26 RCTs included. Patients treated with FBC plus G-TMPs had better objective response (risk ratio [RR] = 1.23, 95% confidence interval [CI]: 1.13 to 1.35, p < 0.00001) and disease control (RR = 1.13, 95% CI: 1.08 to 1.19, p < 0.00001) rates than those treated with FBC alone. Additionally, the combination group had a better QoL, higher proportions of CD3+ T cells, CD4+ T cells, and natural killer cells, as well as a higher CD4+/CD8+ T-cell ratio. Furthermore, lower levels of CA19-9, CA72-4, and CEA were confirmed in the combination treatment group. In addition, G-TMPs reduced the incidence of ADRs during chemotherapy.
Conclusion
In combination with FBC, G-TMPs can potentially enhance efficacy, reduce ADRs, and improve prognosis for patients with AGC. However, high-quality randomized studies remain warranted.
Systematic review registration
PROSPERO Number: CRD42021264938.
Funder
the Special training of scientific and technological talents, China Academy of Chinese Medical Sciences
National Natural Science Foundation of China
Beijing Municipal Science and Technology Commission
Scientific and technological innovation project of China Academy of Chinese Medical Sciences
Traditional Chinese Medicine Innovation Team Project of the National Administration of Traditional Chinese Medicine
Publisher
Public Library of Science (PLoS)
Reference83 articles.
1. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study;Global Burden of Disease Cancer Collaboration;JAMA Oncol,2019
2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;H Sung;CA Cancer J Clin,2021
3. Gastric cancer prevention strategies: a global perspective;LH Eusebi;J Gastroenterol Hepatol,2020
4. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Gastric Cancer, Version 4.2021. https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf. Accessed 13 August 2021.
5. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021;FH Wang;Cancer Commun (Lond),2021